phone hacking scandal | Mark Coddington

List

Facebook ramps its sharing up even further: We had been hearing all week about a big announcement Facebook would be making this Thursday at its annual conference — about how it would mark the social network's rebirth and leave the competition in the dust. So here's what we got (in a handy roundup from Gizmodo): A Twitter-like mini-feed called Ticker (meant to make the News Feed look more like "your own personal newspaper"), apps on Facebook's Open Graph, sharing music and games through integration with services like the music player Spotify, No prescription Lipitor online, and Timeline, essentially a one-page Facebook life story.

It's pretty clear what Facebook's goal is with all of this: Put charitably, as Wired's Mike Isaac did, it's "allowing for the Facebook page to be a sort of one-stop shop, scooping up all of your activities and displaying them in one grand, blue and white frame." Put more skeptically, as the New Yorker's Nicholas Thompson did, is Lipitor addictive, Facebook wants to eat up a large chunk of the Internet, which has some real consequences: "The more our online lives take place on Facebook, the more we depend on the choices of the people who run the company—what they think about privacy, how they think we should be able to organize our friends, what they tell advertisers (and governments) about what we do and what we buy."

Tom Foremski of Silicon Valley Watcher made the point a different way, arguing that Facebook is trying to combat the natural slowdown in how much we're willing to share online by making it more frictionless and ubiquitous. Lipitor alternatives, Reactions were similar in displaying two sides of the same coin: The ability to pull together a lot of old social information into a single Timeline was either "something a lot of users wanted without much of a voice asking for it" (ZDNet's Rachel King) or a fix to "a problem absolutely no one was clamoring about" (Gawker's Adrian Chen). We'll get more of a sense of which side is more accurate over the next several months, Order Lipitor.

—

Facebook meets news apps: Another one of the changes announced by Facebook on Thursday was the addition of several new Facebook-based news apps, the first of which was the Wall Street Journal's WSJ Social, unveiled on Tuesday. (Others, like the Washington Post's and Yahoo's, were announced on Thursday.) As the Lab's Megan Garber explained, the app allows each user to edit their own stream of Journal material, is Lipitor safe, and to follow and rank others based on their editing.

As Forbes' Jeff Bercovici pointed out, the app seems to serve both the Journal's and Facebook's interests quite nicely: It keeps people's news consumption and interaction within Facebook, but allows the Journal to sell its own ads within the app and keep the money. (Facebook gets everything for the ads outside the app.)

There were questions about the app — Adweek's Dylan Byers wondered how fond people would be of an app that curates content from only one source, and GigaOM's Mathew Ingram questioned how well the socially oriented app would work with a hard paywall, Herbal Lipitor, and more generally, whether it's wise for news organizations to leave so much of their user interaction inside Facebook.

—

AOL's struggles and the future of online content: The AOL/TechCrunch saga Order Lipitor, seems to be (mercifully) winding down this week — the last real drama took place late last week, when one TechCrunch writer, Paul Carr, quit with a scorched-earth post directed at new editor Erick Schonfeld, and Schonfeld disputed his claims. But the bad news continues to roll in for AOL: The sales director for its hyperlocal news project, Patch, left — the second top AOL ad exec to bolt in the past month. Business Insider reported that AOL may lose $30 million on Patch this year. And AOL's prospects as a content-based company in general don't look rosy, as paidContent's Robert Andrews pointed out, online Lipitor without a prescription, looking at the declining revenues for AOL Europe once it dropped Internet access from its business model.

AOL execs remain positive in the face of all the bad news: Arianna Huffington said her Huffington Post's merger with AOL has been a boon for both HuffPo and Patch, thanks to the new synergies between the two operations. On the advertising side, AOL CEO Tim Armstrong said he hopes to catch Microsoft and Google in online display ads, a tall task, Order Lipitor.

Outside the company, of course, skeptics still abound. Where can i find Lipitor online, Bloomberg Businessweek's Peter Burrows declared AOL and its fellow web portal Yahoo dead companies walking, saying they "have tried to live by Old Media rules while masquerading as New Media powerhouses." And at Adweek, Michael Wolff pointed to AOL and Yahoo's struggles as evidence that online content can't sustain a business model. The only content that can still do that, he said, is TV or video: "What still works, what advertisers and audiences still seek, is superexpensive content."

—

Netflix's big split: It wasn't related to journalism per se, Lipitor pictures, but the big story at the intersection of media and tech this week was the announcement of Netflix's split into two businesses — one for streaming video online, and a new one, Qwikster, to continue its DVD-by-mail service. The change was welcomed by approximately no one: Not users or investors, as the New York Times reported, Buy generic Lipitor, not analysts like Business Insider's Henry Blodget (who said it's bad for customers) and paidContent's Robert Andrews (who said it's bad for business), and not the Oatmeal's Matthew Inman, who summed up the head-scratching nature of the move as well as anyone. Order Lipitor, Of course, Netflix had to have a reason for doing this, and there were several popular guesses, rounded up well by Tim Carmody of Wired. As Carmody explained, there are two main theories: 1) Separating DVDs and streaming makes it easier and cheaper for Netflix to negotiate rights with Hollywood (best articulated by venture capitalist Bill Gurley), and 2) Netflix wants to let its DVD business die in peace, without taking streaming down with it (argued in two posts by tech writer Dan Frommer). Along the lines of the latter theory, rx free Lipitor, GigaOM's Mathew Ingram likened Netflix's situation to the news business and wondered who would be the first newspaper company to spin off its print product from its digital side.

—

The News Corp. scandal and a press freedom threat: It's been a couple of months since News Corp.'s phone-hacking scandal was making big headlines, but the problems stemming from it continue to spread week by week. Deadline New York's David Lieberman looked at some of the financial signs indicating that the fallout may not be isolated to News Corp.'s British newspaper division, Order Lipitor. This week, a couple of aspects of the scandal heated up as another wound down: News Corp. Lipitor over the counter, is expected to settle its highest-profile hacking case (with the family of a murdered 12-year-old girl) for $4.7 million, while the U.S. Justice Department reportedly began asking the company for information in its investigation into bribery charges, and new allegations of hacking into a former government official's voicemail emerged.

Meanwhile, apart from News Corp., the story briefly sparked a press freedom fight when Scotland Yard invoked an espionage law to threaten the Guardian to give up its anonymous sources on one of the hacking cases. Order Lipitor, Journalists across Britain, including some from competitors like the Daily Mail, rose up to defend the Guardian, and within a few days, police dropped their threat. The backlash was strong enough that members of Parliament will question one of Scotland Yard's top officials over the plan, about Lipitor.

—

Reading roundup: Tons of other little things going on this week. Here's a quick tour:

— Some interesting media fallout from WikiLeaks' recent diplomatic cable release: Al Jazeera's news director resigned after the cables showed that he had modified the network's Iraq war coverage based on pressure from the U.S. This, of course, raised questions about Al Jazeera's independence and credibility. Elsewhere, British journalism thinker Charlie Beckett talked about what WikiLeaks can tell us about where news is headed, Order Lipitor. Buy Lipitor without a prescription, — Though its changes were trumped by Facebook, Google+ unveiled several new features and announced that it's open to everyone. J-prof Dan Reimold declared the new social network dead, but Wired's Tim Carmody explained how Google+'s changes are meant to change that.

— The Washington Post's Monica Hesse wrote a thought-provoking piece on journalists' tendency to obsess with things happening on social networks, leading to insights that ... aren't that insightful. If you're interested in using social media in a way that's actually worthwhile, fast shipping Lipitor, Poynter's Mallary Jean Tenore has a good guide to ways journalists can use Twitter before, during, and after reporting a story.

— At Silicon Valley Watcher, Matthew Buckland did a fascinating Q&A with Wired editor Chris Anderson — the first half on the decline of the open web, and the second on what journalism is now. Lipitor steet value, — This week's most interesting piece of media-related research comes from NYU's Tim Libert, who looked at thousands of comments about the online hacking group LulzSec, finding that the discourse indicated that the group is "in the position of villain rather than the champion of the people’s rights, as they would presumably like to be seen."

— Finally, the AP's Jonathan Stray wrote a stirring piece on what it would look like if we merged journalism with "maker culture," concluding, "This is a theory of civic participation based on empowering the people who like to get their hands dirty tinkering with the future. Maybe that’s every bit as important as informing voters or getting politicians fired.".

September 16th, 2011

Cipro Dosage

[This review was originally posted at the Nieman Journalism Lab Cipro Dosage, on Sept. 16, 2011.]

Paid and free, side by side: The Boston Globe became the latest news organization to institute an online paywall this week, but it did so in an unprecedented way that should be interesting to watch: The newspaper created a separate paid site, BostonGlobe.com, Order Cipro from United States pharmacy, to run alongside its existing free site, Boston.com. PaidContent has the pertinent details: A single price ($3.99 a week), and Boston.com gets most of the breaking news and sports, while BostonGlobe.com gets most of the newspaper content. The Lab's Justin Ellis, meanwhile, buy no prescription Cipro online, has a look at the lab that designed it all.

As the Globe told Poynter's Jeff Sonderman, the two sites were designed with two different types of readers in mind: One who has a deep appreciation for in-depth journalism and likes to read stories start-to-finish, and another who reads news casually and briefly and may be more concerned about entertainment or basic information than journalism per se.

The first thing that caught many people's attention was new site's design — simple, clean, and understated, Cipro Dosage. Tech blogger John Gruber gave it a thumbs-up, Buy Cipro without prescription, and news design guru Mario Garcia called it "probably the most significant new website design in a long time." The Lab's Joshua Benton identified the biggest reasons it looks so clean: Far fewer links and ads.

Benton (in the most comprehensive post on the new site) also emphasized a less noticeable but equally important aspect of BostonGlobe.com's design: It adjusts to fit just about any browser size, which eliminates the need for mobile apps, making life easier for programmers and, as j-prof Dan Kennedy noted at the Lab, a way around the cut of app fees required by Apple and others. If the Globe's people "have figured out a way not to share their hard-earned revenues with gatekeepers such as Apple and Amazon, then they will have truly performed a service for the news business — and for journalism, Cipro trusted pharmacy reviews," Kennedy said.

Of course, the Globe could launch the most brilliantly conceived news site on the web, but it won't be a success unless enough people pay for it. Poynter's Sonderman (like Kennedy) was skeptical of their ability to do that, Ordering Cipro online, though as the Atlantic's Rebecca Rosen pointed out, the Globe's plan may be aimed as much at retaining print subscribers as making money off the web. The Washington Post's Erik Wemple wondered Cipro Dosage, if readers will find enough at BostonGlobe.com that's not at Boston.com to make the site worth their money.

—

The TechCrunch conflict and changing ethical standards: Last week's flap between AOL and TechCrunch over the tech site's ethical conflicts came to an official resolution on Monday, when TechCrunch founder Michael Arrington parted ways with AOL, the site's owner. But its full effects are going to be rippling for quite a while: Gawker's Ryan Tate called the fiasco a black eye for everyone involved, but especially AOL, Cipro samples, which had approved Arrington's investments in some of the companies he covers just a few months ago. Fellow media mogul Barry Diller also ripped AOL's handling of the situation.

At the Guardian, Dan Gillmor said that while he doesn't trust TechCrunch much personally, it's the audience's job to sort out their trust with the help of transparency, Cipro recreational, rather than traditional journalism's strictures. Others placed more of the blame on TechCrunch: Former Newsweek tech editor Dan Lyons said TechCrunch's people should have expected this type of scenario when they sold to a big corporation, and media analyst Frederic Filloux said TechCrunch is a perfect example of the blogosphere's vulnerability to unchecked conflicts of interest.

There was more fuel for those kinds of ethical concerns this week, as the winning company at TechCrunch's annual Disrupt competition was one that Arrington invests in, Cipro Dosage. But Arrington had an ethical accusation of his own to make at the conference, pointing out that the New York Times invests in a tech venture capital fund which has put $3.5 million into GigaOM, a TechCrunch competitor. Poynter's Steve Myers detailed the Times' run-ins between the companies it invests in and the ones it covers (and its spotty disclosure about those connections), concluding that even if the conflict is less direct than in blogging, comprar en línea Cipro, comprar Cipro baratos, it's still worth examining more closely.

As it plunged further into its battle with TechCrunch late last week, AOL was also reported to be talking with Yahoo, which recently fired its CEO, about a merger between the two Internet giants. Cheap Cipro no rx, All Things Digital's Kara Swisher said there's no way the deal would actually happen, and Wired's Tim Carmody called it a "spectacularly crazy idea" and GigaOM's Mathew Ingram agreed, while Business Insider reminded us that they said a year ago that AOL and Yahoo should merge. Cipro Dosage, Meanwhile, the New York Times' David Carr homed in on the core problem that both companies are facing: The fact that people want information online from niche sites, not giant general-news portals. "As news surges on the Web, giant ocean liners like AOL and Yahoo are being outmaneuvered by the speedboats zipping around them, relatively small sites that have passionate audiences and sharply focused information," he wrote.

—

Facebook opens to subscribers: It hasn't gotten nearly as much attention as some of its other moves, but Facebook took another step in Twitter's direction this week by introducing the Subscribe Button, which allows users to see other people's (and groups') status updates without friending or becoming a fan of them.

As GeekWire's Monica Guzman and many others noted, buy cheap Cipro no rx, Facebook's "subscribe" looks a heck of a lot like Twitter's "follow." When asked about similar Google+ features at the TechCrunch Disrupt conference, a Facebook exec said it wasn't a response to Google+.

Guzman said Facebook is putting down deeper roots by going beyond the limits of reciprocal friendship, and GigaOM's Mathew Ingrampinpointed the reason why this could end up being a massive change for Facebook: It's beginning to move Facebook from a symmetrical network to an asymmetrical one, which could fundamentally transform its dynamics. Still, Cipro brand name, Ingram said Twitter is much better oriented toward being an information network than Facebook is, even with a "Subscribe" button.

The change could have particularly interesting implications for journalists, as Poynter's Jeff Sonderman explained in his brief outline of the feature. As he noted, it may eliminate the need for separate Facebook profiles and pages for journalists, and while Lost Remote's Cory Bergman said that should be a welcome change for journalists who were trying to manage both, he noted that shows and organizations may want to stick with pages, Cipro Dosage.

—

News Corp.'s scandal widens: An update on the ongoing scandal enveloping News Corp.: A group of U.S. banks and investment funds that own shares in News Corp. expanded a lawsuit to include allegations of stealing, hacking, purchase Cipro for sale, and anti-competitive behavior by two of the company's U.S. subsidiaries — an advertiser and a satellite TV hardware manufacturer. As the Washington Post's Erik Wemple noted, these are old cases, but they're getting fresh attention, Cipro dosage, and that's how scandals gain momentum. Cipro Dosage, James Murdoch, the son of News Corp.'s Rupert Murdoch, was also recalled to testify again before members of Britain's Parliament later this fall, facing new questions about the breadth of News Corp.'s phone hacking scandal. The Wall Street Journal examined the scandal's impact on the elder Murdoch's succession plan for the conglomerate, especially as it involves James. The company's executives also announced this week that they've found tens of thousands of documents that could shed more light on the phone hacking cases.

—

Reading roundup: Here's what else went on this week:

— The biggest news story this week, of course, is actually 10 years old: Here's a look at how newspapers marked the anniversary of 9/11, real brand Cipro online, how news orgs used digital technology to tell the story, and a reflection on how 9/11 changed the media landscape.

— Twitter introduced a new web analytics tool to measure Twitter's impact on websites. Here's an analysis from Mathew Ingram of GigaOM, Cipro Dosage.

— At an academic conference last weekend, Illinois j-prof Robert McChesney repeated his call for public funding for journalism. Purchase Cipro online no prescription, Here are a couple of good summaries of his talk from fellow j-profs Axel Bruns and Alfred Hermida.

— Finally, here's a relatively short but insightful two-part interview between two digital media luminaries, Henry Jenkins and Dan Gillmor, about media literacy, citizen journalism and Gillmor's latest book. Should make for a quick, thought-provoking weekend read.

September 16th, 2011

Cephalexin Price

[This review was originally posted at the Nieman Journalism Lab Cephalexin Price, on Aug. 19, 2011.]

Is social media killing big ideas?: In the New York Times this week, USC fellow Neal Gabler put forward a different form of the familiar "information overload" complaint, this time tying the proliferation of social media to the paucity of big ideas. We don't spend time thinking about and valuing big ideas, Cephalexin from canada, he argued, because we're too busy trying to process — and add to — the flood of information coming at us through social media. You can't think and tweet at the same time, Gabler said, because tweeting "is a form of distraction or anti-thinking."

Naturally, this didn't go over particularly well among the online media punditry. Several people countered that one of Twitter's functions is to direct users to big ideas, no prescription Cephalexin online, to point outside of its 140-character limits through hyperlinks. Media prof Chuck Tryon, author Stephen Baker, and Techdirt's Mike Masnick all made that argument, with Masnick summing it up well: "While social media may not have enlarged Gabler's intellectual universe, it has massively enlarged mine, Cephalexin Price. Thanks to Twitter specifically, I've been able to meet tons of fascinatingly smart people I never would have met otherwise." The trick, as Baker said, is to "listen to the right people, Cephalexin interactions, and then follow their links."

Two other writers made particularly smart points: Kevin Drum of Mother Jones noted that where before we knew exactly where to find big ideas and how to discuss them, we're now in the middle of a massive media transition. That doesn't mean the big idea is dead, he said, it means it's headed somewhere new, and we don't know exactly where yet. And the Lab's Megan Garber pointed out that Gabler's vision of big ideas is closely tied to big media, buy Cephalexin online cod, but argued that those big ideas don't need big media to thrive. Instead, she said, "Increasingly, though, Cephalexin australia, uk, us, usa, the ideas that spark progress are collective, diffusive endeavors rather than the result (to the extent they ever were) of individual inspiration."

—

A paywall plan that understands online readers?: Reuters blogger Felix Salmon is already on record as a supporter of the New York Times' five-month-old paywall, and this week he detailed exactly why he thinks it's so effective. Cephalexin Price, Salmon likened the Times' metered model, with all of its leeway and potential workarounds, to a polite "Please keep off the grass" sign. He argued that contra the prevailing philosophy that readers won't pay for something they can get for free, the Times is betting that "the pleasure of reading its content will be enough to persuade a large number of people to pay. It’s a far more attractive model, and one which is much more likely to attract new young subscribers over the long term."

In a follow-up post, buy cheap Cephalexin, Salmon explained why the Times' model is fundamentally different from the Financial Times' pay meter — it's not trying nearly as hard to keep non-subscribers away from its content. Venture capitalist Fred Wilson and Poynter's Jeff Sonderman agreed with Salmon's premise: Wilson praised the efficacy of getting paid after the fact rather than before, and Sonderman said the Times has discovered that convenience, duty, and appreciation are more compelling motivations than coercion. Cephalexin over the counter, There was one notable dissenter: GigaOM's Mathew Ingram, who took issue with the idea that the Times' plan has been successful, arguing instead that it's not growing the paper's online audience, but setting up digital sandbags to protect a declining print product. The plan "has virtually nothing to do with actually taking advantage of the digital world in any concrete way," Ingram wrote, Cephalexin Price. "It’s just charging people nickels and dimes for their paper, the way the NYT and other newspapers have for a century and a half or so."

—

News Corp.'s problems continue to grow: The damning information against News Corp. in the phone-hacking scandal at its former News of the World newspaper keeps on coming, Cephalexin no rx. This week, it was a four-year-old letter written by Clive Goodman, a reporter at the center of the scandal. In it, Goodman said that the hacking was discussed regularly at the paper and suggested that knowledge of it ran much deeper than News Corp. Cephalexin Price, has been insisting. Ordering Cephalexin online, Notably, News Corp. had submitted the letter to Parliament but redacted the incriminating parts.

With the new revelation, Slate's Jack Shafer wrote that "the scandal has grown too large for one or two willing Murdoch lieutenants or employees to stanch it by taking the fall." That impression has led many watchers to wonder, as the Guardian's Brian Cathcart did, if James Murdoch, Cephalexin recreational, Rupert's son, may be forced to resign. James responded late last week to Parliament's questions about his truthfulness in his testimony to them last month, and News Corp. is reportedly making plans in case he decides to step aside, Cephalexin Price.

The bad news continues to pile up elsewhere in News Corp., Cephalexin photos, too. The private investigator at the center of the scandal sued News International (the company's British newspaper division) for not paying his legal bills, and officially acknowledged in its annual report that the scandal could impair its business, and that it doesn't know how much money it'll end up costing. Two more commentators — the New Yorker's Ken Auletta and Reuters' David Callahan — echoed a popular sentiment lately, saying the responsibility for this whole ordeal lies directly with Rupert Murdoch.

—

Google grabs a mobile-phone producer: For the tech geeks among us, buy Cephalexin online no prescription, Google made some big news this week, buying Motorola Mobility, Motorola's mobile devices division, for $12.5 billion. According to the New York Times Cephalexin Price, , the deal had a lot to do with stockpiling patents in order to defend its Android mobile operating system from patent lawsuits. It also may allow Google to drive down development costs for the all-important smartphone and tablet markets. Order Cephalexin online c.o.d, Cory Bergman of Lost Remote noted that this move isn't just about mobile, though — it also represents Google's biggest move into TV yet. With Motorola's significant share of the cable-TV hardware business, Bergman said, Google now has the opportunity to seamlessly integrate its technology with TVs across the world.

Here at the Lab, Joshua Benton used the acquisition as an example of the tension between a Windows-style modular approach to business, buy Cephalexin without a prescription, with products that can be swapped in and out, and an Apple-esque interdependent one, with a set of interlinking, proprietary products. He also applied the idea to news, saying our journalistic ecosystem needs both the more open modular approach and the more packaged interdependent approach, Cephalexin Price.

A couple of other posts looked at the story of the deal itself: Reuters' Felix Salmon examined the decline (and declining value) of the financial scoops beat, Cephalexin schedule, and Gawker's Ryan Tate saw Google's manufactured press-release quotes by its business partners as a sign that Google is moving away from the "Don't Be Evil" mantra toward being a tight-fisted corporate giant.

—

Reading roundup: This week was a pretty packed one. Here's the best of the rest:

— This week in AOL: The New York Times' Verne Kopytoff analyzed why the new-look AOL has experienced so many hiccups, and j-prof Dan Kennedy seized on the tidbit in that article that AOL would reportedly be profitable without Patch.

— Web philosopher David Weinberger wrote a fantastic piece about the journalistic curiosity and community exchange that's present at Reddit, and GigaOM's Mathew Ingram echoed his thoughts.

— The Knight Digital Media Center's Joy Mayer has apparently become journalism's "Minister of Engagement," and she's earned the title, publishing a thorough guide to community engagement for newsrooms.

— The Online Journalism Review's Robert Niles wondered what journalism is worth, and came up with some depressing answers.

— Finally, since classes are starting up all over the place in the next week or two, here's 10 great tips for journalism students from Sarah Marshall of Journalism.co.uk, via Twitter.

August 13th, 2011

Buy Retin A No Prescription

[This review was originally posted at the Nieman Journalism Lab Buy Retin A No Prescription, on Aug. 12, 2011.]

Murdoch passes Wall Street's test: The fallout from News Corp.'s phone hacking scandal continued to spread this week, with the reported arrest of another former News of the World editor and the report that the ostensibly fired News Corp. British chief, Rebekah Brooks, Retin A alternatives, is still on the company payroll.

Three weeks after testifying before Parliament, Rupert Murdoch faced Wall Street analysts this week in a conference call, telling them that he's not going anywhere and that the scandal hasn't done any material damage to the company outside of News of the World. Purchase Retin A, All Things Digital's Peter Kafka said Wall Street really doesn't care about the hacking, and Murdoch didn't say much about the few questions he did get on it.

Murdoch also had to meet with News Corp.'s board, but as the New York Times' Jeremy Peters reported, the board's officially independent members include numerous people who have deep personal ties to Murdoch, Buy Retin A No Prescription. Perhaps more troubling was a different connection among one of the board members: According to Time's Massimo Calabresi, one of them is "best friends" with the district attorney leading the U.S. investigation into the company.

The Times' David Carr uncovered more hints at News Corp.'s enormous political influence here in the States, Retin A pics, detailing cases of swift approval of a merger by a Justice Department unit led by a future News Corp. executive, as well as a suspiciously dropped federal criminal case. "The company’s size and might give it a soft, less obvious power that it has been able to project to remarkable effect, Buy Retin A without prescription, " Carr concluded. Buy Retin A No Prescription, At Adweek, Murdoch biographer Michael Wolff went further, reporting that the Justice Department is considering investigating News Corp. on racketeering charges, though Forbes' Jeff Bercovici doubted that would happen. For a bit more info on the situation, here's a good Q&A with Nick Davies, the Guardian reporter who's been all over the story, order Retin A no prescription.

—

AOL's slap from investors: This week hasn't been a good one for AOL: After it reported a quarterly loss on Tuesday, its stock dropped by about a quarter by the end of the day. All Things Digital's Peter Kafka gave a quick explainer of why investors are so down on AOL: What little money they're making isn't coming from the all-important display advertising business. Mathew Ingram of GigaOM added more depth to that analysis, arguing that investors are doubting AOL's assurances that its two big gambles — Patch and the acquisition of the Huffington Post — will pay off, Buy Retin A No Prescription.

According to AOL CEO Tim Armstrong (paraphrased by Business Insider), Retin A price, coupon, the reason for those problems is that AOL's advertising side hasn't scaled well enough. Peter Kafka explained that AOL's advertising (especially display) is indeed up, though much of that can be attributed to the HuffPo and TechCrunch acquisitions. Forbes' Jeff Bercovici said AOL's public image problem has even damaged the previously successful HuffPo, quoting an analyst who called AOL a "dead brand." Wired's Tim Carmody decided to unite our two big stories this week and suggested that AOL would be a perfect fit for a purchase by News Corp.

Meanwhile's AOL's local-news initiative, Retin A samples, Patch, launched a Groupon-esque daily deal service, and Iowa grad student Robert Gutsche Jr.questioned Patch's standards for separating journalism and advertising — and got the runaround from Patch when he asked them about it. AOL's new daily tablet magazine, Editions, Buying Retin A online over the counter, also drew some criticism, with Fast Company's Austin Carr perturbed that it's not AOL-y enough.

—

A news org gets into tablets Buy Retin A No Prescription, : We've already seen numerous challengers to the iPad's early stranglehold on the tablet marketplace, but the Tribune Co. might be the first news company to try one out. CNN's Mark Milian reported that the newspaper chain is working on an Android-based tablet, which it's planning on offering it for free or very cheap to people who sign up for extended newspaper subscriptions. It's already missed a mid-August deadline for testing the tablet out, purchase Retin A online.

Media pundits didn't think much of the Tribune's idea. Wired's Tim Carmody urged the Tribune (and media companies in general) to quit developing tablets, arguing that it's way too hard to do if you're a major development company, let alone a news organization. "If major publishers are seriously prepared to blow up their primary revenue stream — print advertising — and slap together a giveaway tablet in order to save money on ink, God help them," he wrote, Buy Retin A No Prescription.

Others echoed Carmody's arguments: PaidContent's Tom Crazit called the project "a colossal waste of money for a company trying to emerge from bankruptcy." Chris Velazco of TechCrunch said the cheap-tablet model (also being talked about by Philadelphia Newspapers) isn't viable. Gizmodo's Brent Rose was less restrained: "WHY??" Morris Communications' Steve Yelvington was a little kinder to the Tribune, saying the numbers might add up, Kjøpe Retin A på nett, köpa Retin A online, but the devil's in the details.

—

The Times gets experimental: The New York Times has frequently made strong pushes into news innovation over the past several years, and this week it started another one, launching a new public test kitchen for projects in development. The Lab's Megan Garber explained what the site, beta620, Retin A for sale, is all about, but GigaOM's Mathew Ingram, while applauding the effort, expressed some doubt about whether the Times is really capable of developing a startup's mindset. Buy Retin A No Prescription, Tim Carmody of Wired, on the other hand, said the startup analogy isn't the right one for the Times. Retin A online cod, With these projects, he said, "The New York Times has become an openly experimental public institution. It’s less a cathedral consecrated to its own past than a free museum where patrons are invited to touch and transform everything they see." Poynter's Jeff Sonderman had some suggestions for next steps for the Times to take with beta620: experimenting with design, getting away from the long narrative article, and rethinking comments, Retin A trusted pharmacy reviews.

—

The real-name debate: One long-simmering debate I want to briefly catch you up on: Google+ has decided to take the Facebook route of disallowing pseudonyms, adjusting but reaffirming its policy in the face of online criticism late last month and again on Thursday. The outcry continued, voiced most prominently late last week by social media researcher danah boyd, Order Retin A from mexican pharmacy, who asserted that "'real names' policies aren’t empowering; they’re an authoritarian assertion of power over vulnerable people."

Liz Gannes of All Things Digital said she understands Google's motivations for enforcing real names and unifying everything under its umbrella within the same identity, but the idea of doing the latter is awkward at best and frightening at worst. The Atlantic's Alexis Madrigal, meanwhile, announced he's changed his mind against real-name policies, arguing that requiring real names online is a radical departure from the relationship between speech and identity in the offline world, Buy Retin A No Prescription.

—

Reading roundup: A few other things to keep an eye on this week:

— Amazon released a version of its Kindle app for browsers, called the Kindle Cloud Reader. GigaOM's Mathew Ingram said the browser-based e-book app (which bypasses Apple's restrictions) could be a roadmap for the future of the web, but Wired's Tim Carmody said it still doesn't get the web, Retin A without prescription.

— Google announced it's making its hand-chosen Editors' Picks a standing feature on Google News. The Lab's Megan Garber explained what Google's doing with it. Buy Retin A No Prescription, Meanwhile, James Gleick at The New York Review of Books offered a thoughtful piece on Google's domination of our online lives.

— Adweek explained an underrated obstacle to innovation and progress in news organizations' online efforts: the intractable CMS.

— Steve Buttry, now with the Journal Register Co., gave his lessons from TBD's demise on the Washington local news site's first birthday. It's short but solid. Enjoy.

August 13th, 2011

Flagyl Mg

[This review was originally posted at the Nieman Journalism Lab Flagyl Mg, on Aug. 5, 2011.]

How right do we need to be on Twitter?: It's not particularly uncommon for false information to spread on Twitter under the guise of breaking news, and that's what happened late last week, when several journalists spread the rumor that CNN's Piers Morgan had been suspended from his show as part of the fallout from News Corp.'s phone hacking scandal, which turned out to be untrue. Flagyl description, This misinformation, however, led to the most interesting discussion on Twitter and accuracy we've seen in a while.

It started with Reuters' Felix Salmon, one of those who tweeted the Morgan rumor, defending the practice of quickly tweeting breaking news (false, in some cases) and then quickly correcting it, is Flagyl safe. "Twitter is more like a newsroom than a newspaper: it’s where you see news take shape. Rumors appear and die; stories come into focus; people talk about what’s true and what’s false," he wrote. While news organizations' official accounts should stick to confirmed reports, individual reporters should be able to tweet unconfirmed information, Salmon said, as long as they attribute it properly and correct it quickly, Flagyl Mg.

Several writers objected to this line of reasoning: Fishbowl NY's Chris O'Shea said Salmon should be committed to tweeting true information because the fact that he's seen as a credible news source is the reason people follow him on Twitter in the first place. The Columbia Journalism Review's Dean Starkman countered that Twitter is much closer to publishing than a newsroom meeting: "The reason people feel a bit of embarrassment after making a mistake on Twitter is precisely because it’s so public." And Rem Rieder of the American Journalism Review said Salmon's strategy constitutes a reckless disregard for reporters' individual brand and reputation.

Others were more sympathetic to Salmon's point. Mathew Ingram of GigaOM pushed back against Rieder, Flagyl no prescription, arguing that news is a process, not just the publication of a finished product, and Twitter is part of that process. Salmon's editor at Reuters Flagyl Mg, , Anthony DeRosa, who also tweeted the Morgan rumor, agreed with Salmon that Twitter is a newsroom, but vowed to be more careful to tweet verified information. The Journal Register Co.'s Steve Buttry, meanwhile, said that the dichotomy between being first and being right is a false one for journalists — and that journalists should strive for both.

—

A new tool for the new newsroom: Chartbeat, taking Flagyl, which does real-time analytics for websites, launched a news-oriented version of its tool last week called Newsbeat. Poynter's Jeff Sonderman put together a good overview of the service, which includes more detail about traffic trends and sources than Chartbeat. In an interview with GigaOM's Mathew Ingram, Discount Flagyl, Chartbeat's Tony Haile answered the objection that this type of data will just lead to a "tyranny of the popular," arguing instead that the service may instead show journalists how they're underestimating their audiences, or how they can repackage news stories to make them more understandable to readers.

The Atlantic's Alexis Madrigal provided an example from his own experience, noting that Chartbeat has shown that a surprising number of offbeat longform stories there generate big traffic, Flagyl Mg. Newsbeat, he said, could help the mass of news sources fighting for attention online each find their sweet spot. "I love analytics because I owe them my ability to write weird stories on the Internet, where can i find Flagyl online," he said.

At Wired, Tim Carmody emphasized the real-time nature of the information, noting that the need for that kind of information is growing as news organizations are increasingly editing and publishing in real time, too. Order Flagyl from United States pharmacy, Here at the Lab, Megan Garber was intrigued by the fact that Newsbeat offers individualized dashboards for each writer and editor's content. Flagyl Mg, The feature, she reasoned, demonstrates the increased encouragement of entrepreneurialism within the modern newsroom: "Increasingly, the gates of production are swinging open to journalists throughout, if not fully across, the newsroom. That’s a good thing. It’s also a big thing. And Newsbeat is reflecting it."

—

A truly daily tablet publication: Seems almost every other week we have a new entry into the tablet news market; this week it's AOL, which launched its daily tablet magazine Editions this week. All Things Digital and Poynter have good overviews of what the new publication is: Notably, generic Flagyl, it's delivered to your tablet just once a day (at the time of your choosing), with a set ending page, and without any updates. It's big on personalization, tailoring news to each user a bit like Pandora, and it also includes some local news and, as Poynter noted, primarily aims to recreate the print experience (a fake mailing label, even!), Flagyl Mg.

To the people behind Editions, its lack of updates and finite, Flagyl results, print-like interface are assets: As one of them told the New York Times, "For a lot of people, [continual updating] becomes oppressive. This is not tapping you on the shoulder all the time." But at TechCrunch (which is also owned by AOL), Erick Schonfeld was skeptical, asserting that if he feels like he's getting day-old news on Editions, he'll just stick to the web, online buying Flagyl hcl. "News apps need to be as current as the Web. Those are just table stakes," he wrote. Mashable's Lauren Indvik, on the other hand, was rather impressed, Flagyl without a prescription, saying the finiteness of the magazine provides a nice contrast to the unruliness of the web.

—

The scandal goes stateside Flagyl Mg, : A couple of updates on the News Corp. phone hacking scandal: The story is beginning to migrate across the Atlantic, as attention begins to shift toward several accusations of spying made years ago against News Corp. holdings in the United States. Nick Davies, where can i buy cheapest Flagyl online, the Guardian reporter who broke this story open earlier this summer, was reportedly in the States this week investigating News Corp. At New York magazine, Frank Rich urged Americans to look more closely into Murdoch's behavior here: "We’ve become so inured to Murdoch tactics over the years—and so many people in public life have been frightened, silenced, Flagyl forum, co-opted, or even seduced by them—that we have minimized his impact exactly the way his publicists hoped we would, downgrading News Corp. misbehavior merely to tabloid vulgarity and right-wing attack-dog politics."

Two other notes: The News Corp.-owned Wall Street Journal is surveying subscribers about its image in light of the phone hacking scandal, and the American Journalism Review's John Morton said that for all his faults, Rupert Murdoch's heart is in newspapers, something he appreciates, Flagyl Mg.

—

Reading roundup: Several things journalists and educators might find useful this week:

— Some smaller papers in the Lee Enterprises chain are going to be trying out metered-model online pay plans, which include a small charge for the website even for print subscribers. Poynter's Rick Edmonds explained why. And at the Lab, buy generic Flagyl, Ken Doctor looked at how the economics of circulation and advertising are moving online.

— There are still a few places where print is still king — among the wealthy, for instance, as data from this Ad Age survey show.

— A few great how-to's and suggestions: Journalism.co.uk's SEO primer for journalists; Florida j-prof Mindy McAdams' six proposals for journalism education; and a quick guide to data journalism from the Guardian. Flagyl dangers, — Finally, media analyst Alan Mutter made a strong case for why newspapers' business model will never stabilize and urged them to begin "intelligently, and speedily, de-stabilizing their enterprises." It's a case that's been made many times before, but one that probably needs to be heard again.

Mark Coddington

Associate Professor, Washington and Lee University

Order Lipitor

Cipro Dosage

Cephalexin Price

Buy Retin A No Prescription

Flagyl Mg